Latest News and Press Releases

1 November 2016 15:30 Transaction by Person Closely Associated with a Person Discharging Managerial Responsibilities Disclosure under Articles 19(3) and 19(6) of the EU Market Abuse Regulation On...

31 October 2016 13:45 ASTRAZENECA COMPLETES AGREEMENT WITH ARALEZ FOR BETA-BLOCKER MEDICINE TOPROL-XL IN THE US AstraZeneca today announced the completion of...

27 October 2016 16:50 ASTRAZENECA HEAD AND NECK CANCER TRIALS Following the recent update on clinicaltrials.gov, AstraZeneca confirms that the US FDA has placed a partial clinical hold on the...

This announcement contains inside information 26 October 2016 07:00 LYNPARZA PHASE III SOLO-2 TRIAL SHOWS SIGNIFICANT PROGRESSION-FREE SURVIVAL BENEFIT Trial studied Lynparza as maintenance...

18 October 2016 [07:00] AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a complete re-submission of a New Drug Application (NDA) for sodium zirconium...

This announcement contains inside information 4 October 2016 07:05 ASTRAZENECA ENTERS AGREEMENT WITH ARALEZ FOR BETA-BLOCKER MEDICINE TOPROL-XL IN THE US AstraZeneca today announced that it has...

This announcement contains inside information 04 October 2016 07:00 ASTRAZENECA REPORTS TOP-LINE RESULTS FROM THE BRILINTA EUCLID TRIAL IN PATIENTS WITH PERIPHERAL ARTERY DISEASE Brilinta did not...

3 October 2016 15:00 Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule...

This announcement contains inside information 03 October 2016 07:00 AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing...

28 September 2016 07:00 CHANGE TO ASTRAZENECA BOARD OF DIRECTORS AstraZeneca today announced that Dr Cornelia (Cori) Bargmann, a Non-Executive Director, will step down from the Board of AstraZeneca...